Novel Therapeutic Agent For Amyotrophic Lateral Sclerosis (Als) Or Disease Attributable To Als - EP1714960

PATENT ANALYSIS

Patent Details

Grant Date
Mar 28, 2018
Oppositions

MAIWALD GMBH

More patents of Mitsubishi Pharma Corporation

Want to monitor this patent?

Feel free to send us a message here and we will get back to you